• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SF-6D健康状态效用评分分析:贝塔回归是否适用?

Analysis of SF-6D Health State Utility Scores: Is Beta Regression Appropriate?

作者信息

Kharroubi Samer A

机构信息

Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut 1107-2020, Lebanon.

出版信息

Healthcare (Basel). 2020 Dec 1;8(4):525. doi: 10.3390/healthcare8040525.

DOI:10.3390/healthcare8040525
PMID:33271844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7712516/
Abstract

: Typically, modeling of health-related quality of life data is often troublesome since its distribution is positively or negatively skewed, spikes at zero or one, bounded and heteroscedasticity. : In the present paper, we aim to investigate whether Bayesian beta regression is appropriate for analyzing the SF-6D health state utility scores and respondent characteristics. : A sample of 126 Lebanese members from the American University of Beirut valued 49 health states defined by the SF-6D using the standard gamble technique. Three different models were fitted for SF-6D via Bayesian Markov chain Monte Carlo (MCMC) simulation methods. These comprised a beta regression, random effects and random effects with covariates. Results from applying the three Bayesian beta regression models were reported and compared based on their predictive ability to previously used linear regression models, using mean prediction error (MPE), root mean squared error (RMSE) and deviance information criterion (DIC). : For the three different approaches, the beta regression model was found to perform better than the normal regression model under all criteria used. The beta regression with random effects model performs best, with MPE (0.084), RMSE (0.058) and DIC (-1621). Compared to the traditionally linear regression model, the beta regression provided better predictions of observed values in the entire learning sample and in an out-of-sample validation. : Beta regression provides a flexible approach to modeling health state values. It also accounted for the boundedness and heteroscedasticity of the SF-6D index scores. Further research is encouraged.

摘要

通常,与健康相关的生活质量数据建模往往很麻烦,因为其分布呈正偏态或负偏态,在零或一处有峰值,有界且具有异方差性。在本文中,我们旨在研究贝叶斯β回归是否适合分析SF - 6D健康状态效用得分和受访者特征。从贝鲁特美国大学抽取了126名黎巴嫩成员作为样本,他们使用标准博弈技术对由SF - 6D定义的49种健康状态进行了评估。通过贝叶斯马尔可夫链蒙特卡罗(MCMC)模拟方法对SF - 6D拟合了三种不同的模型。这些模型包括β回归、随机效应模型以及带协变量的随机效应模型。报告了应用这三种贝叶斯β回归模型的结果,并基于它们相对于先前使用的线性回归模型的预测能力进行比较,使用平均预测误差(MPE)、均方根误差(RMSE)和离差信息准则(DIC)。对于这三种不同的方法,发现在所有使用的标准下,β回归模型的表现均优于正态回归模型。带随机效应的β回归模型表现最佳,MPE为(0.084),RMSE为(0.058),DIC为(-1621)。与传统的线性回归模型相比,β回归在整个学习样本和样本外验证中对观测值提供了更好的预测。β回归为健康状态值建模提供了一种灵活的方法。它还考虑了SF - 6D指数得分的有界性和异方差性。鼓励进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ba/7712516/68c731f4e525/healthcare-08-00525-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ba/7712516/e772899c39a5/healthcare-08-00525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ba/7712516/68c731f4e525/healthcare-08-00525-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ba/7712516/e772899c39a5/healthcare-08-00525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ba/7712516/68c731f4e525/healthcare-08-00525-g002a.jpg

相似文献

1
Analysis of SF-6D Health State Utility Scores: Is Beta Regression Appropriate?SF-6D健康状态效用评分分析:贝塔回归是否适用?
Healthcare (Basel). 2020 Dec 1;8(4):525. doi: 10.3390/healthcare8040525.
2
Use of Bayesian methods to model the SF-6D health state preference based data.贝叶斯方法在 SF-6D 健康状态偏好模型中的应用。
Health Qual Life Outcomes. 2018 Dec 18;16(1):234. doi: 10.1186/s12955-018-1068-7.
3
A Bayesian Nonparametric Approach for Modeling SF-6D Health State Utility Scores.贝叶斯非参数方法在 SF-6D 健康状态效用评分模型中的应用。
Value Health Reg Issues. 2022 Jan-Feb;27:1-11. doi: 10.1016/j.vhri.2021.02.004. Epub 2021 Nov 13.
4
Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population.评估黎巴嫩人群中 SF-6D 阿拉伯语版本的可行性和可接受性。
Int J Environ Res Public Health. 2020 Feb 6;17(3):1037. doi: 10.3390/ijerph17031037.
5
Analysis of SF-6D index data: is beta regression appropriate?SF-6D 指数数据分析:贝塔回归是否适用?
Value Health. 2011 Jul-Aug;14(5):759-67. doi: 10.1016/j.jval.2010.12.009. Epub 2011 May 31.
6
The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.开发一种将 Neck Disability Index (NDI)转化为颈椎疾病成本效用分析中效用评分的模型。
Spine J. 2012 Jan;12(1):55-62. doi: 10.1016/j.spinee.2011.12.002. Epub 2011 Dec 29.
7
Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study.从甲状腺癌患者 FACT-H&N 中获取 SF-6D 效用值:一项映射研究的制定与结果。
Front Endocrinol (Lausanne). 2023 Aug 17;14:1160882. doi: 10.3389/fendo.2023.1160882. eCollection 2023.
8
Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China.从 Lung cancer FACT-L 预测 SF-6D 效用评分:在中国的映射研究。
Health Qual Life Outcomes. 2023 Nov 14;21(1):122. doi: 10.1186/s12955-023-02209-8.
9
Estimating the SF-6D value set for a population-based sample of Brazilians.估算基于巴西人群的 SF-6D 值集。
Value Health. 2011 Jul-Aug;14(5 Suppl 1):S108-14. doi: 10.1016/j.jval.2011.05.012.
10
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.使用多发性硬化症影响量表来估算健康状态效用值:从 MSIS-29 版本 2 到 EQ-5D 和 SF-6D 的映射。
Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4.

引用本文的文献

1
Quality of life in older adults is enhanced by piano practice: Results from a randomized controlled trial.钢琴练习可提高老年人的生活质量:一项随机对照试验的结果
Ann N Y Acad Sci. 2025 Aug;1550(1):239-254. doi: 10.1111/nyas.15397. Epub 2025 Jun 26.
2
Comparison of statistical methods for the analysis of patient-reported outcomes (PROs), particularly the Short-Form 36 (SF-36), in randomised controlled trials (RCTs) using standardised effect size (SES): an empirical analysis.在使用标准化效应量(SES)的随机对照试验(RCT)中,对用于分析患者报告结局(PROs),特别是简短健康调查问卷36项版本(SF-36)的统计方法进行比较:一项实证分析。
Health Qual Life Outcomes. 2025 Apr 29;23(1):45. doi: 10.1186/s12955-025-02373-z.
3

本文引用的文献

1
Predictors of (in)efficiencies of Healthcare Expenditure Among the Leading Asian Economies - Comparison of OECD and Non-OECD Nations.亚洲主要经济体医疗保健支出(无)效率的预测因素——经合组织国家与非经合组织国家的比较
Risk Manag Healthc Policy. 2020 Oct 21;13:2261-2280. doi: 10.2147/RMHP.S266386. eCollection 2020.
2
SF-6Dv2 preference value set for health utility in food allergy.用于食物过敏健康效用的SF-6Dv2偏好值集。
Allergy. 2021 Jan;76(1):326-338. doi: 10.1111/all.14444. Epub 2020 Jul 6.
3
Cost-effectiveness and resource allocation (CERA) 18 years of evolution: maturity of adulthood and promise beyond tomorrow.
Disease diagnosis and arthroplasty type are strongly associated with short-term postoperative patient-reported outcomes in patients undergoing primary total shoulder arthroplasty.
疾病诊断和关节置换类型与初次全肩关节置换术后患者的短期术后患者报告结局密切相关。
J Shoulder Elbow Surg. 2024 Jun;33(6):e308-e321. doi: 10.1016/j.jse.2024.01.028. Epub 2024 Feb 29.
成本效益与资源分配(CERA)18年的发展历程:步入成熟及未来展望。
Cost Eff Resour Alloc. 2020 Apr 2;18:15. doi: 10.1186/s12962-020-00210-2. eCollection 2020.
4
Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With Duration.采用具有持续时间的离散选择实验评估英国的 SF-6Dv2 分类系统
Med Care. 2020 Jun;58(6):566-573. doi: 10.1097/MLR.0000000000001324.
5
Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population.评估黎巴嫩人群中 SF-6D 阿拉伯语版本的可行性和可接受性。
Int J Environ Res Public Health. 2020 Feb 6;17(3):1037. doi: 10.3390/ijerph17031037.
6
Knowledge of sexually transmitted infections and risky behaviours: a survey among high school and university students.性传播感染知识与危险行为:一项针对高中生和大学生的调查
J Prev Med Hyg. 2019 Jun 28;60(2):E84-E92. doi: 10.15167/2421-4248/jpmh2019.60.2.1079. eCollection 2019 Jun.
7
Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2.三种不同方式施测短式 6 维度版本 2 的一致性。
Value Health. 2019 Jul;22(7):837-842. doi: 10.1016/j.jval.2018.12.012. Epub 2019 May 17.
8
Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?基于偏好的衡量标准的评估:能否使用现有的偏好数据来选择更小的健康状态样本?
Eur J Health Econ. 2019 Mar;20(2):245-255. doi: 10.1007/s10198-018-0991-1. Epub 2018 Jul 6.
9
Valuation of preference-based measures: can existing preference data be used to generate better estimates?基于偏好的衡量指标的评估:现有的偏好数据是否可以用来生成更好的估计值?
Health Qual Life Outcomes. 2018 Jun 5;16(1):116. doi: 10.1186/s12955-018-0945-4.
10
A Comparison of Japan and U.K. SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method.使用非参数贝叶斯方法对日本和英国SF-6D健康状态估值的比较
Appl Health Econ Health Policy. 2015 Aug;13(4):409-20. doi: 10.1007/s40258-015-0171-8.